[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.168.111.191. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,011
Citations 0
Correction
February 2019

Error in Results Sections

JAMA Psychiatry. 2019;76(2):219. doi:10.1001/jamapsychiatry.2019.0067

In the Original Investigation titled “Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study,”1 published online December 19, 2018, and in the February print issue of JAMA Psychiatry, there was an error in a 95% CI in the Results section of the abstract and the text. The 95% CI for the effect size for the insomnia score should be −0.61 to −0.02, not −0.65 to 0.02. The article has been corrected online.

×